Can the host immune response against SARS-CoV2 also cause an anticancer effect?

During the COVID-19 pandemic, it is important to assure the safety and management of cancer patients. Despite preliminary studies revealed that patients with cancer are more susceptible to infection and have poorer prognosis than other infected patients without cancer, mortality from COVID-19 in can...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahraman, Seda, Akinci, Muhammed Bulent, Sendur, Mehmet Ali Nahit, Yalcin, Bulent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243040/
https://www.ncbi.nlm.nih.gov/pubmed/34191146
http://dx.doi.org/10.1007/s12032-021-01533-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243040/
https://www.ncbi.nlm.nih.gov/pubmed/34191146
http://dx.doi.org/10.1007/s12032-021-01533-7

Ejemplares similares